Inhibition of neutrophil superoxide production by uremic concentrations of guanidino compounds

Journal of the American Society of Nephrology

Volumn 11, Issue 4, 2000, Pages 684-689

  Hirayama, Aki ^a   Noronha Dutra, Alberto A ^a   Gordge, Michael P ^a   Neild, Guy H ^a   Hothersall, John S ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b INSTITUTE OF UROLOGY AND NEPHROLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; BUTYRIC ACID DERIVATIVE; CREATINE PHOSPHATE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GLUTATHIONE; GUANIDINE DERIVATIVE; GUANIDINOPROPIONIC ACID; GUANIDINOSUCCINIC ACID; LACTIC ACID; PHORBOL 13 ACETATE 12 MYRISTATE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; ZYMOSAN;

ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME ACTIVITY; HOST RESISTANCE; HUMAN; HUMAN CELL; LEUKOCYTE METABOLISM; NEUTROPHIL; OXIDATIVE STRESS; PRIORITY JOURNAL; UREMIA;

EID: 0034023797     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Mailloux LU, Bellucci AG, Wilkers BM: Mortality in dialysis patients: Analysis of the causes of death. Am J Kidney Dis 18: 326-335, 1991
2. Hoen B, Kessler M, Hestin D, Mayeux D: Risk factors for bacterial infections in chronic haemodialysis adult patients: A multicentre prospective survey. Nephrol Dial Transplant 10: 377-381, 1995
3. Haag-Weber M, Hörl WH: Dysfunction of polymorphonuclear leukocytes in uremia. Semin Nephrol 16: 199-201, 1996
4. Porter CJ, Burden RP, Morgan AG, Daniels I, Fletcher J: Impaired polymorphonuclear neutrophil function in end-stage renal failure and its correction by continual ambulatory peritoneal dialysis. Nephron 71: 133-137, 1995
5. Vanholder R, De Smet R, Jacobs V, Van Landschoot N, Waterloos MA, Vogeleere P, Ringoir S: Uraemic toxic retention solutes depress polymorphonuclear response to phagocytosis. Nephrol Dial Transplant 9: 1271-1278, 1994
6. Vanholder R, Ringoir S, Dhondt A, Hakim R: Phagocytosis in uraemic and hemodialysis patients: A prospective cross sectional study. Kidney Int 39: 320-327, 1991
7. Cendoroglo M, Jaber BL, Balakrishnan VS, Perianayagam M, King AJ, Pereira BJC: Neutrophil apoptosis and dysfunction in uremia. J Am Soc Nephrol 10: 93-100, 1999
8. Vanholder R, De Smet R, Waterloos MA, Van Landschoot N, Vogeleere P, Hoste E, Ringoir S: Mechanisms of uremic inhibition of phagocyte reactive species production: Characterization of the role of p-cresol. Kidney Int 47: 510-517, 1995
9. De Deyn P, Marescau B, Lornoy W, Becaus I, Van Leuven I, Van Gorp L, Löwenthal A: Serum guanidino compound levels and the influence of a single hemodialysis in uremic patients undergoing maintenance hemodialysis. Nephron 45: 291-295, 1987
10. Asaka M, Iida H, Izumino K, Sasayama S: Depressed natural killer cell activity in uremia: Evidence for immunosuppressive factor in uremic sera. Nephron 49: 291-295, 1988
11. Zweier JC, Jacobus WE, Korecky B, Brandejs-Barry Y: Bioenergetic consequences of cardiac phosphocreatine depletion induced by creatine analogue feeding. J Biol Chem 266: 20296-20304, 1991
12. Boehm EA, Tadda GK, Tomlin H, Clark JF: The utilisation of creatine and its analogues by cytosolic and mitochondrial creatine kinase. Biochim Biophys Acta 1274: 119-128, 1996
13. Roberts PJ, Devereux S, Pilkington GR, Linch DC: FcγRII-mediated superoxide production by phagocytes is augmented by GM-CSF without a change in Fcγ-RII expression. J Leukocyte Biol 48: 247-257, 1990
14. Jabs CM, Ferrell WJ, Robb HJ: Microdetermination of plasma ATP and creatine phosphate concentrations with a luminescence biometer. Clin Chem 23: 2254-2257, 1977
15. Epperlein MM, Nourooz-Zadeh J, Jayasena SD, Hothersall JS, Noronha-Dutra A, Neild GH: Nature and biological significance of free radicals generated during bicarbonate hemodialysis. J Am Soc Nephrol 9: 457-463, 1998
16. Downs TR, Wilfinger WW: Fluorometric quantification of DNA in cells and tissue. Anal Biochem 131: 538-547, 1983
17. Grant SK, Green BG, Stiffey-Wilusz J, Durette PL, Shah SK, Kozarich JW: Structural requirements for human inducible nitric oxide synthase substrates and substrate analogue inhibitors. Biochemistry 37: 4174-4180, 1998
18. MacAllister RJ, Whitley GSJ, Vallance P: Effect of guanidino and uremic compounds on nitric oxide pathways. Kidney Int 45: 737-742, 1994
19. Borregaard N, Herlin T: Energy metabolism of human neutrophils during phagocytosis. J Clin Invest 70: 550-557, 1982
20. Holtzman D, Meyers R, O'Gorman E, Khait I, Wallimann T, Allred E, Jensen F: In vivo brain phosphocreatine and ATP regulation in mice fed creatine analog. Am J Physiol 272: C1567-C1577, 1997
21. Aoyagi K, Nagase S, Gotoh M, Akiyama K, Satoh M, Hirayama A, Koyama A: Role of reactive oxygen and argininosuccinate in guanidinosuccinate synthesis in isolated rat hepatocytes. Enzyme Protein 49: 205-211, 1996
22. Burkey TH, Webster RO: Adenosine inhibits fMLP-stimulated adherence and superoxide anion generation by human neutrophils at an early step in signal transduction. Biochim Biophys Acta 1175: 312-318, 1993
23. Ward RA, McLeish KR: Polymorphonuclear leukocyte oxidative burst is enhanced in patients with chronic renal insufficiency. J Am Soc Nephrol 5: 1697-1702, 1995